Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 272Leukemia 194Precursor Cell Lymphoblastic Leukemia-Lymphoma 131Lymphoma 108Congenital Abnormalities 68Myelodysplastic Syndromes 63Leukemia, Myelomonocytic, Acute 60Leukemia, Monocytic, Acute 58Leukemia, Erythroblastic, Acute 56Leukemia, Megakaryoblastic, Acute 54Lymphoma, Non-Hodgkin 51Burkitt Lymphoma 44Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 41Lymphoma, Follicular 33Leukemia, Myelomonocytic, Chronic 28Anemia, Refractory, with Excess of Blasts 27Hodgkin Disease 26Recurrence 25Lymphoma, Large-Cell, Immunoblastic 25Leukemia, Lymphocytic, Chronic, B-Cell 25Blast Crisis 24Leukemia, Eosinophilic, Acute 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Myeloproliferative Disorders 17Leukemia, Basophilic, Acute 17Lymphoma, B-Cell, Marginal Zone 16Leukemia, Promyelocytic, Acute 16Leukemia, Myeloid, Chronic-Phase 15Leukemia, Myeloid, Accelerated Phase 14

Interventions

Imatinib Mesylate 3nilotinib 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dasatinib 1Cytarabine 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hypereosinophilic Syndrome × Cytarabine × Clear all
NCT00483067 2012-08-02

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

M.D. Anderson Cancer Center

Phase 2 Completed
13 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Hypereosinophilic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡